ALG-006780

N/A

Report date: 2024/07/16 11:54:53
NME

Base Information

Drug NameALG-006780
Drug Alias NameALG-006780
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg inhibitors
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAligos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAligos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A